Metformin inhibits early stage diethylnitrosamine-induced hepatocarcinogenesis in rats
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jo, Woori | - |
dc.contributor.author | Yu, Eun-Sil | - |
dc.contributor.author | Chang, Minsun | - |
dc.contributor.author | Park, Hyun-Kyu | - |
dc.contributor.author | Choi, Hyun-Ji | - |
dc.contributor.author | Ryu, Jae-Eun | - |
dc.contributor.author | Jang, Sungwoong | - |
dc.contributor.author | Lee, Hyo-Ju | - |
dc.contributor.author | Jang, Ja-June | - |
dc.contributor.author | Son, Woo-Chan | - |
dc.date.available | 2021-02-22T11:30:04Z | - |
dc.date.issued | 2016-01 | - |
dc.identifier.issn | 1791-2997 | - |
dc.identifier.issn | 1791-3004 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/9963 | - |
dc.description.abstract | Antitumor effects of metformin have recently emerged despite its original use for type II diabetes. In the present study, the effects of metformin on the development and recurrence of hepatocellular carcinoma (HCC) were investigated using the diethylnitrosamine (DEN)-induced rat model of HCC. Tumor foci were characterized by gross examination and by histopathological characteristics, including proliferation, hepatic progenitor cell content and the expression of hepatocarcinoma-specific molecular markers. Potential target molecules of metformin were investigated to determine the molecular mechanism underlying the inhibitory effects of metformin on chemically induced liver tumorigenesis. The antitumor effects of metformin were increased by the reduction of surface nodules and decreased the incidence of altered hepatocellular foci, hepatocellular adenoma and carcinoma. Also, decreased expression levels of glutathione S-transferase placental form, proliferating cell nuclear antigen and cytokeratin 8 described the inhibitory effects of metformin on HCC. In the present study, Wistar rats receiving treatment with DEN were administered metformin for 16 weeks. In addition, metformin suppressed liver tumorigenesis via an AMPK-dependent pathway. These results suggested that metformin has promising effects on the early stage of HCC in rats. Therefore, metformin may be used for the prevention of HCC recurrence following primary chemotherapy for HCC and/or for high-risk patients, including chronic hepatitis and cirrhosis. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPANDIDOS PUBL LTD | - |
dc.title | Metformin inhibits early stage diethylnitrosamine-induced hepatocarcinogenesis in rats | - |
dc.type | Article | - |
dc.publisher.location | 그리이스 | - |
dc.identifier.doi | 10.3892/mmr.2015.4513 | - |
dc.identifier.scopusid | 2-s2.0-84954235076 | - |
dc.identifier.wosid | 000367867500020 | - |
dc.identifier.bibliographicCitation | MOLECULAR MEDICINE REPORTS, v.13, no.1, pp 146 - 152 | - |
dc.citation.title | MOLECULAR MEDICINE REPORTS | - |
dc.citation.volume | 13 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 146 | - |
dc.citation.endPage | 152 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | ACTIVATED PROTEIN-KINASE | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | DEPENDENT MANNER | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | LIVER | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | AMPK | - |
dc.subject.keywordAuthor | rat | - |
dc.subject.keywordAuthor | metformin | - |
dc.subject.keywordAuthor | diethylnitrosamine | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | AMP-activated protein kinase | - |
dc.identifier.url | https://www.spandidos-publications.com/10.3892/mmr.2015.4513 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.